Aiyana AmessAiyana Amess is a market analyst at Signify Research.UltrasoundBeyond commoditization: How ultrasound AI vendors can thriveA new article from Signify Research discusses current market dynamics for ultrasound AI.January 28, 2026Page 1 of 1Top StoriesWomens ImagingAI approach could improve DBT efficiencyAI-based slab reconstruction may help improve screening DBT workflows while not compromising on image quality.SNMMI 2026SNMMI: Incoming president talks meeting highlights, previews next yearSNMMI 2026SNMMI: Biomarkers predict I-131 response in obese thyroid cancer patientsRisk ManagementPodcast: Telltale signs your MRI safety standards are inadequateSNMMI 2026SNMMI: Theranostic approach may treat PSMA-negative prostate cancer
![RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding peptide tracer [⁶⁸Ga]Ga-DOTA-RET-L7 in a neuroendocrine prostate cancer (NEPC) model, supporting highly specific, high-contrast detection.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/05/screenshot-2026-05-27-205827.278Ys6PYU3.png?auto=format%2Ccompress&fit=crop&h=167&q=70&w=250)
